Shinpoong Pharmaceutical Co.,Ltd (KRX:019175)

South Korea flag South Korea · Delayed Price · Currency is KRW
19,200
-80 (-0.41%)
Feb 25, 2026, 3:30 PM KST
Market Cap650.67B +19.9%
Revenue (ttm)231.90B +7.6%
Net Income-3.71B
EPS-74.01
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,994
Average Volume3,783
Open19,500
Previous Close19,280
Day's Range19,200 - 19,500
52-Week Range9,650 - 55,000
Beta1.35
RSI36.63
Earnings DateMar 20, 2026

About KRX:019175

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun... [Read more]

Sector Healthcare
Founded 1962
Employees 809
Stock Exchange Korea Stock Exchange
Ticker Symbol 019175
Full Company Profile

Financial Performance

In 2024, KRX:019175's revenue was 221.09 billion, an increase of 10.42% compared to the previous year's 200.23 billion. Losses were -14.82 billion, -74.15% less than in 2023.

Financial Statements